Immunome Inc.

IMNM | NASDAQ

Price Alert Chart Builder DCF Calculator

$25.57

+$0.50 (+1.99%)

Sep 22, 2026, 11:40 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Quarter Period Ending	Q2 2026 Jun 29, 2026	Q1 2026 Mar 30, 2026	Q4 2025 Dec 30, 2025	Q3 2025 Sep 29, 2025	Q2 2025 Jun 29, 2025	Q1 2025 Mar 30, 2025	Q4 2024 Dec 30, 2024	Q3 2024 Sep 29, 2024	Q2 2024 Jun 29, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023	Q3 2023 Sep 29, 2023	Q2 2023 Jun 29, 2023	Q1 2023 Mar 30, 2023	Q4 2022 Dec 30, 2022	Q3 2022 Sep 29, 2022	Q2 2022 Jun 29, 2022	Q1 2022 Mar 30, 2022	Q4 2021 Dec 30, 2021	Q3 2021 Sep 29, 2021	Q2 2021 Jun 29, 2021	Q1 2021 Mar 30, 2021
Revenue	n/a	n/a	n/a	n/a	4.02M	2.93M	2.74M	2.91M	2.36M	1.03M	3.83M	3.57M	4.26M	2.36M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	753K	n/a	49.19M	720K	n/a	n/a	n/a	n/a	n/a	n/a	166K	5.72M	3.91M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	-753K	n/a	-49.19M	3.3M	2.93M	2.74M	2.91M	2.36M	1.03M	3.83M	3.4M	-1.45M	-1.55M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-78.14M	-59.33M	-72.86M	-60.14M	-46.48M	-44.64M	-82.97M	-50.52M	-40.01M	-132.3M	-94.65M	-4.63M	-5.77M	-4.47M	-7.79M	-8.53M	-8.93M	-11.65M	-7.84M	-7.72M	-5.74M	-3.9M
Interest Income	5.01M	5.49M	2.96M	2.68M	3.08M	3M	2.72M	3.42M	3.89M	2.81M	2.02M	288K	216K	201K	1K	1K	2K	1K	n/a	n/a	n/a	n/a
Pretax Income	-73.13M	-53.84M	-69.9M	-57.46M	-43.4M	-41.64M	-80.25M	-47.1M	-36.12M	-129.49M	-92.63M	-4.35M	-5.56M	-4.27M	-7.79M	-8.53M	-8.92M	-11.65M	-7.85M	-7.72M	-5.24M	-3.9M
Net Income	-73.13M	-53.84M	-69.9M	-57.46M	-43.4M	-41.64M	-80.25M	-47.1M	-36.12M	-129.49M	-92.63M	-4.35M	-5.56M	-4.27M	-7.79M	-8.53M	-8.92M	-11.65M	-7.85M	-7.72M	-5.24M	-3.9M
Selling & General & Admin	18.25M	12.95M	12.09M	10.95M	10.04M	10.69M	10.45M	9.53M	6.98M	6.01M	8.04M	4.38M	4.32M	2.92M	3.54M	3.31M	3.21M	3.58M	3.46M	3.21M	2.51M	1.92M
Research & Development	59.89M	46.38M	60.77M	49.19M	40.45M	36.87M	47.89M	37.2M	29.08M	15.37M	9.64M	3.82M	5.72M	3.91M	4.25M	5.23M	5.72M	8.08M	4.39M	4.51M	3.23M	1.98M
Other Expenses	n/a	-753K	n/a	-49.19M	-720K	n/a	27.37M	6.71M	6.31M	111.95M	80.8M	-166K	-5.72M	-3.91M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	78.14M	58.58M	72.86M	10.95M	49.77M	47.56M	85.71M	53.43M	42.37M	133.33M	98.48M	8.03M	4.32M	2.92M	7.79M	8.53M	8.93M	11.65M	7.84M	7.72M	5.74M	3.9M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	5K	3K	1K	1K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	78.14M	59.33M	72.86M	60.14M	50.49M	47.56M	85.71M	53.43M	42.37M	133.33M	98.48M	8.2M	10.04M	6.84M	7.79M	8.53M	8.93M	11.65M	7.84M	7.72M	5.74M	3.9M
Income Tax Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	113.27M	113.14M	87.35M	87.96M	87.01M	79.41M	62.7M	60.21M	59.94M	10.31M	21.95M	12.2M	12.2M	12.18M	12.13M	12.13M	12.06M	12.12M	11.93M	11.88M	11.39M	10.64M
Shares Outstanding (Diluted)	113.27M	113.14M	87.35M	87.96M	87.01M	79.41M	62.7M	60.21M	59.94M	10.31M	21.95M	12.2M	12.2M	12.18M	12.13M	12.13M	12.13M	12.12M	11.93M	11.93M	11.46M	10.64M
EPS (Basic)	-0.65	-0.48	-0.76	-0.65	-0.50	-0.52	-1.28	-0.78	-0.60	-12.56	-4.22	-0.36	-0.46	-0.33	-0.69	-0.70	-0.74	-0.96	-0.66	-0.65	-0.46	-0.37
EPS (Diluted)	-0.65	-0.48	-0.76	-0.65	-0.50	-0.52	-1.28	-0.78	-0.60	-12.56	-4.22	-0.36	-0.46	-0.33	-0.69	-0.70	-0.74	-0.96	-0.66	-0.65	-0.46	-0.37
EBITDA	-72.17M	-53.09M	-69.12M	-56.87M	-42.68M	-40.91M	-55M	-43.25M	-33.02M	-20.08M	-13.59M	-4.18M	-5.46M	-4.18M	-7.53M	-8.42M	-8.8M	-11.52M	-7.73M	-7.43M	-5.07M	-3.72M
EBIT	-73.13M	-53.84M	-69.9M	-57.46M	-43.4M	-41.64M	-55.6M	-43.82M	-33.7M	-20.35M	-13.85M	-4.35M	-5.56M	-4.27M	-7.79M	-8.53M	-8.92M	-11.65M	-7.85M	-7.72M	-5.24M	-3.9M
Depreciation & Amortization	957K	753K	776K	589K	720K	726K	595K	571K	673K	263K	257K	166K	101K	94K	260K	114K	121K	136K	118K	286K	175K	176K